Microspheres as nasal drug delivery systems

被引:96
作者
Pereswetoff-Morath, L [1 ]
机构
[1] Astra Arcus AB, S-15185 Sodertalje, Sweden
关键词
nasal administration; microspheres; bioavailability; absorption enhancer; absorption mechanism; ciliotoxicity; mucociliary clearance; mucosal toxicity;
D O I
10.1016/S0169-409X(97)00069-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
All types of microspheres that have been used as nasal drug delivery systems are water-insoluble but absorb water into the sphere's matrix, resulting in swelling of the spheres and the formation of a gel. The building materials in the microspheres have been starch, dextran, albumin and hyaluronic acid, and the bioavailability of several peptides and proteins has been improved in different animal models. Also, some low-molecular weight drugs have been successfully delivered in microsphere preparations. The residence time in the cavity is considerably increased for microspheres compared to solutions. However, this is not the only factor to increase the absorption of large hydrophilic drugs. Microspheres also exert a direct effect on the mucosa, resulting in the opening of tight junctions between the epithelial cells. Starch and dextran microspheres have been administered repeatedly and can be classified as safe dosage forms. (C) 1998 Elsevier Science B.V.
引用
收藏
页码:185 / 194
页数:10
相关论文
共 40 条
[1]   IMMUNE-RESPONSE TO NASAL DELIVERY OF ANTIGENICALLY INTACT TETANUS TOXOID ASSOCIATED WITH POLY(L-LACTIC ACID) MICROSPHERES IN RATS, RABBITS AND GUINEA-PIGS [J].
ALMEIDA, AJ ;
ALPAR, HO ;
BROWN, MRW .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1993, 45 (03) :198-203
[2]  
ALPAR HO, 1994, EUR J PHARM BIOPHARM, V40, P198
[3]   MORPHOLOGICAL EXAMINATION OF RABBIT NASAL-MUCOSA AFTER NASAL ADMINISTRATION OF DEGRADABLE STARCH MICROSPHERES [J].
BJORK, E ;
BJURSTROM, S ;
EDMAN, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1991, 75 (01) :73-80
[4]   STARCH MICROSPHERES INDUCE PULSATILE DELIVERY OF DRUGS AND PEPTIDES ACROSS THE EPITHELIAL BARRIER BY REVERSIBLE SEPARATION OF THE TIGHT JUNCTIONS [J].
BJORK, E ;
ISAKSSON, U ;
EDMAN, P ;
ARTURSSON, P .
JOURNAL OF DRUG TARGETING, 1995, 2 (06) :501-507
[5]   CHARACTERIZATION OF DEGRADABLE STARCH MICROSPHERES AS A NASAL DELIVERY SYSTEM FOR DRUGS [J].
BJORK, E ;
EDMAN, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 62 (2-3) :187-192
[6]   DEGRADABLE STARCH MICROSPHERES AS A NASAL DELIVERY SYSTEM FOR INSULIN [J].
BJORK, E ;
EDMAN, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1988, 47 (1-3) :233-238
[7]  
BJORK E, 1993, THESIS UPPSALA U SWE
[8]   IMMUNE-RESPONSES AND PROTECTION AGAINST BORDETELLA-PERTUSSIS INFECTION AFTER INTRANASAL IMMUNIZATION OF MICE WITH FILAMENTOUS HEMAGGLUTININ IN SOLUTION OR INCORPORATED IN BIODEGRADABLE MICROPARTICLES [J].
CAHILL, ES ;
OHAGAN, DT ;
ILLUM, L ;
BARNARD, A ;
MILLS, KHG ;
REDHEAD, K .
VACCINE, 1995, 13 (05) :455-462
[9]   Nasal-associated lymphoid tissue is an inductive site for rat tear IgA antibody responses [J].
Carr, RM ;
Lolachi, CM ;
Albaran, RG ;
Ridley, DM ;
Montgomery, PC ;
OSullivan, NL .
IMMUNOLOGICAL INVESTIGATIONS, 1996, 25 (5-6) :387-396
[10]  
CONTE U, 1994, EUR J PHARM BIOPHARM, V40, P203